UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-02, Vol.41 (2), p.213-228

2018

Volltextzugriff (PDF)

Economic Implications of Sleep Disorders

PharmacoEconomics, 2010-11, Vol.28 (11), p.1015-1023

2010

Volltextzugriff (PDF)

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Clinical drug investigation, 2017-08, Vol.37 (8), p.763-773

2017

Volltextzugriff (PDF)

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-06, Vol.41 (6), p.643-644

2018

Volltextzugriff (PDF)

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

PharmacoEconomics, 2014, Vol.32 (1), p.5-13

2014

Volltextzugriff (PDF)

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018-02, Vol.18 (1), p.65-71

2018

Volltextzugriff (PDF)

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Clinical drug investigation, 2012-02, Vol.32 (2), p.139-144

2012

Volltextzugriff (PDF)

Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010-01, Vol.10 (2), p.105-108

2010

Volltextzugriff (PDF)

Comment on: "All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population"/Reply

Drug safety, 2018-06, Vol.41 (6), p.641-644

2018

Volltextzugriff (PDF)

Noncompliance with antihypertensive therapy. Economic consequences

PharmacoEconomics, 1996-01, Vol.9 (1), p.1-4

1996

Volltextzugriff (PDF)

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States

Clinical drug investigation, 2012-02, Vol.32 (2), p.139

2012

Volltextzugriff (PDF)

The need for an iterative process for assessing economic outcomes associated with SSRIs

PharmacoEconomics, 2000-09, Vol.18 (3), p.205-214

2000

Volltextzugriff (PDF)

Anxiety Disorders in the USA, 1990 to 1997: Trend in Complaint, Diagnosis, Use of Pharmacotherapy and Diagnosis of Comorbid Depression

Clinical drug investigation, 2000-10, Vol.20 (4), p.255-265

2000

Volltextzugriff (PDF)

Psychiatric Comorbidity and Pharmacological Treatment Patterns among Patients Presenting with Insomnia: An Assessment of Office-Based Encounters in the USA in 1995 and 1996

Clinical drug investigation, 1999, Vol.18 (2), p.161-167

1999

Volltextzugriff (PDF)

Antidepressant prescribing patterns: a comparison of blacks and whites in a medicaid population

Clinical drug investigation, 1998, Vol.16 (2), p.135-140

1998

Volltextzugriff (PDF)

Remifentanil, Fentanyl, or the Combination in Surgical Procedures in the United States: Predictors of Use in Patients with Organ Impairment or Obesity

Clinical drug investigation, 2015-01, Vol.35 (1), p.53-59

Sclar, David Alexander

2015

Volltextzugriff (PDF)

U.S. Supreme Court Ruling in Gonzales v. Oregon Upholds the Oregon Death With Dignity Act

The Journal of law, medicine & ethics, 2006-09, Vol.34 (3), p.639-646

Sclar, David

2006

Volltextzugriff (PDF)

[alpha]^sub 1^-Proteinase Inhibitor (Human) in the Treatment of Hereditary Emphysema Secondary to [alpha]^sub 1^-Antitrypsin Deficiency: Number and Costs of Years of Life Gained

Clinical drug investigation, 2012-05, Vol.32 (5), p.353

2012

Volltextzugriff (PDF)

Recent Developments in Health Law

The Journal of law, medicine & ethics, 2006-09, Vol.34 (3), p.632-646

2006

Volltextzugriff (PDF)

α1-Proteinase Inhibitor (Human) in the Treatment of Hereditary Emphysema Secondary to α1-Antitrypsin Deficiency: Number and Costs of Years of Life Gained

Clinical drug investigation, 2012-05, Vol.32 (5), p.353-360

2012

Volltextzugriff (PDF)

Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea

Clinical drug investigation, 2013-03, Vol.33 (3), p.229-229

2013

Volltextzugriff (PDF)

Fidaxomicin for Clostridium difficile-Associated Diarrhoea: Epidemiological Method for Estimation of Warranted Price

Clinical drug investigation, 2012-08, Vol.32 (8), p.e17-e24

2012

Volltextzugriff (PDF)

Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological method for estimation of warranted price

Clinical drug investigation, 2012-08, Vol.32 (8), p.e17-e24

2012

Volltextzugriff (PDF)

Pharmaceutical formulation and healthcare expenditures

PharmacoEconomics, 1992-10, Vol.2 (4), p.267-269

1992

Volltextzugriff (PDF)

Sunshine and strategy: managing and monitoring compliance with PPACA's sunshine provisions - evolving legal requirements and operational considerations

The Health Lawyer, 2012-06, Vol.24 (5), p.14

2012

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni (LexisNexis)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(24)
magazinearticle
(1)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Economic Implications of Sleep Disorders

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

Comment on: "All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population"/Reply

Noncompliance with antihypertensive therapy. Economic consequences

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States

The need for an iterative process for assessing economic outcomes associated with SSRIs

Anxiety Disorders in the USA, 1990 to 1997: Trend in Complaint, Diagnosis, Use of Pharmacotherapy and Diagnosis of Comorbid Depression

Psychiatric Comorbidity and Pharmacological Treatment Patterns among Patients Presenting with Insomnia: An Assessment of Office-Based Encounters in the USA in 1995 and 1996

Antidepressant prescribing patterns: a comparison of blacks and whites in a medicaid population

Remifentanil, Fentanyl, or the Combination in Surgical Procedures in the United States: Predictors of Use in Patients with Organ Impairment or Obesity

U.S. Supreme Court Ruling in Gonzales v. Oregon Upholds the Oregon Death With Dignity Act

[alpha]^sub 1^-Proteinase Inhibitor (Human) in the Treatment of Hereditary Emphysema Secondary to [alpha]^sub 1^-Antitrypsin Deficiency: Number and Costs of Years of Life Gained

Recent Developments in Health Law

α1-Proteinase Inhibitor (Human) in the Treatment of Hereditary Emphysema Secondary to α1-Antitrypsin Deficiency: Number and Costs of Years of Life Gained

Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea

Fidaxomicin for Clostridium difficile-Associated Diarrhoea: Epidemiological Method for Estimation of Warranted Price

Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological method for estimation of warranted price

Pharmaceutical formulation and healthcare expenditures

Sunshine and strategy: managing and monitoring compliance with PPACA's sunshine provisions - evolving legal requirements and operational considerations

Aktive Filter

Suchergebnisse filtern